Le Lézard
Classified in: Health
Subjects: PER, WOM, DEI

FINN Partners Promotes Jessica A. Lise to Partner, New York Health

NEW YORK, Nov. 30, 2022 /PRNewswire/ -- Global independent marketing and communications firm FINN Partners today promotes Jessica A. Lise to Partner, New York Health. The promotion recognizes Lise's important contributions to providing industry-leading client service and growing FINN's New York Health group.  It also is an acknowledgement of her initiative and leadership in mentoring colleagues and embodying the FINN philosophy of "work hard, play nice."

Jess frequently serves as right-hand to the communications and PR leads at FINN client companies, working to establish a deep understanding of corporate and brand goals and objectives in order to better design high-level communications strategies and tactically execute against them to consistently exceed client expectations. Prior to her promotion, Lise was Vice President, New York Health. In her new role, she reports to Tom Jones, Managing Partner, Head, New York Health and Pharma Sector, and will serve on the Global Health Practice Leadership Team.

"Our Health Practice relies on dynamic leaders who innovate and advance the state of the industry. Since joining FINN, Jess has proven to be that leader to her growing group of account teams and all her colleagues," said Jones. "Team members look up to Jess; she is a tremendous role model to all in delivering on the important function of learning and development, leading with a 'people first' mentality. We're fortunate to call Jess our colleague and friend and look forward to her continued journey here at FINN."

Lise joined FINN in 2019 as an Associate Vice President, managing projects for specific accounts, and was promoted to Vice President in May 2020. Through her effort and leadership, Jess has won important new business for the agency and led account teams with the result of significantly increasing clients' visibility and influence.

"Jess is a steward of FINN culture in every sense of the word," said Fern Lazar, Managing Partner, Global Health Practice Leader at FINN Partners. "She is actively involved in the FINN DEI committee, working to spearhead several initiatives such as the PRSSA partnership and mentorship program to ensure an inclusive and accessible world and an even better work environment at FINN. She takes pride in fostering learning and development for her teams, paying forward the mentorship she has received throughout her career."

Prior to joining FINN, Lise worked at the health public relations and communications firm RXMOSAIC since 2014, where she became Senior Account Supervisor. Lise is a graduate of St. John's University.

About FINN Partners, Inc.??

Founded in 2011 on the core principles of innovation and collaborative partnership, FINN Partners has grown from about $24 million in fees to almost $200 million in fees during the past 10 years, becoming one of the fastest-growing independent public relations agencies in the world and recognized as a PRovoke Media 2022 Agency of the Year. The full-service marketing and communications company's record-setting pace results from organic growth and integrating new companies and new people into the FINN world through a common philosophy. With more than 1,400 professionals across 33 offices, FINN provides clients with global access and capabilities in the Americas, Europe and Asia. In addition, FINN provides its clients with access to top-tier agencies worldwide through its membership in the global network PROI.

Headquartered in New York, FINN has offices in: Atlanta, Bangalore, Beijing, Boston, Chicago, Delhi, Denver, Detroit, Dublin, Fort Lauderdale, Frankfurt, Guam, Hong Kong, Honolulu, Jerusalem, Kuala Lumpur, London, Los Angeles, Manila, Mumbai, Munich, Nashville, Orange County, Paris, Portland, San Diego, San Francisco, Seattle, Shanghai, Singapore, Vancouver and Washington D.C. Find us at finnpartners.com and follow us on Twitter and Instagram at @finnpartners.

Contact: Celia Jones, [email protected]


These press releases may also interest you

at 14:56
Egret Therapeutics, a clinical-stage biotechnology company focused on developing transformative therapies for neurological conditions, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND)...

at 14:25
The next Gentle Sleep Coach® online certification training program hosted by world-leading children's sleep coach, 'The Sleep Lady®' returns. Aligned with her gentle sleep philosophy, the program welcomes aspiring sleep coaches to participate in...

at 12:55
The number of patients seeking medical/dental care abroad, a practice called "medical...

at 09:30
A University of Maryland School of Medicine (UMSOM) physician-scientist will head a new federally-funded research program to develop and test a whole blood product, storable at room temperature, that can be used to transfuse wounded soldiers in the...

at 08:07
The National Comprehensive Cancer Network® (NCCN®)?a not-for-profit alliance...

at 08:00
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sotera Health Company ("Sotera" or the "Company") and reminds investors of the March 27, 2023 deadline to seek the role of lead plaintiff in a...

News published on 30 november 2022 at 08:00 and distributed by: